Gelteq Limited Ordinary Shares(GELS)

Drug Manufacturers - Specialty & Generic · Clayton, VIC

$0.53-0.02 (-3.06%)

Delayed quote: Oct 6, 2026, 9:34 AM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T13:36:59.957Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:59.957Z.

Quote observation: 2026-10-06T13:34:25.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 4,838,235
Total debt · period ending 2025-12-31: 3,412,541.5042
Cash · period ending 2025-12-31: 6,238.5877
TTM free cash flow · period ending 2024-06-30: N/A

FMP input reference: 6ebeba272bae7de15d59b23151f0025007a9c632b25eeddd13cd9ab927e6ebe5

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

GELS EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

GELS Competitors' EV/FCF Ratio

GELS

Gelteq Limited Ordinary Shares

Current

Market Cap

$4.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CALC

CalciMedica, Inc.

vs GELS

Market Cap

$4.82M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs GELS

Market Cap

$4.80M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LEXX

Lexaria Bioscience Corp.

vs GELS

Market Cap

$4.63M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMGL

Basel Medical Group Ltd Ordinary Shares

vs GELS

Market Cap

$5.07M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLGN

CollPlant Biotechnologies Ltd.

vs GELS

Market Cap

$4.54M

EV/FCF Ratio

N/A

TTM Avg

57.42x

3Y Avg

57.42x

5Y Avg

57.42x

DRMA

Dermata Therapeutics, Inc.

vs GELS

Market Cap

$4.50M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ERNA

Ernexa Therapeutics Inc.

vs GELS

Market Cap

$4.49M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMNN

Imunon, Inc.

vs GELS

Market Cap

$5.21M

EV/FCF Ratio

N/A

TTM Avg

11.91x

3Y Avg

14.69x

5Y Avg

14.69x

AIDX

20/20 Biolabs Inc.

vs GELS

Market Cap

$4.42M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Gelteq Limited Ordinary Shares (GELS)	$4.84M	N/A	N/A	N/A	N/A
CalciMedica, Inc. (CALC)vs ›	$4.82M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.80M	N/A	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$4.63M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.07M	N/A	N/A	N/A	N/A
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.54M	N/A	57.42x	57.42x	57.42x
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.50M	N/A	N/A	N/A	N/A
Ernexa Therapeutics Inc. (ERNA)vs ›	$4.49M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.21M	N/A	11.91x	14.69x	14.69x
20/20 Biolabs Inc. (AIDX)vs ›	$4.42M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

GELS EV/FCF Ratio Metrics

GELS Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics